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Tuesday, February 28, 2012 455aamyloid fibrils cause neuronal dysfunction in neurodegenerative diseases
such as Alzheimer’s disease and Parkinson’s disease. Biochemical and cell
biological studies indicate that amyloid formation pathways can be manipu-
lated with small molecules. This suggests that stimulation of amyloid polymer-
ization with small molecules might reduce the prevalence of transient, toxic
aggregation intermediates. We have recently demonstrated the acceleration
of alpha-synuclein and Abeta fibrillogenesis through the action of the orcein-
related small mole-
cule, which leads to
a decrease in toxic-
ity neuronal cell
models.
These results sup-
port the hypothesis
that small, diffusible
pre-fibrillar amyloid
species rather than
mature fibrillar ag-
gregates are toxic for mammalian cells. They also suggest that compound-
mediated acceleration of amyloidogenesis might be a promising therapeutic
strategy for amyloid diseases.
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Amyloid diseases, such as Alzheimer’s disease, are neurodegenerative disor-
ders that have been introduced by protein misfoldings into amyloid fibrils.
The Amyloid Precursor Protein irregularly cleaves the b-amyloid (Ab) peptide,
causing protein misfoldings to aggregate to form the hallmark plaques. For both
Ab(1-40) and Ab(1-42), a tendency of fibril formation has demonstrated to self-
assemble from a non-toxic monomer state to a lethal fibrillar state. Prior re-
search focused only on the 16-21 region of the peptide, however, it is equally
important to examine the hair-pin region without the presence of residues 16-
21. In order to study the effect on fibril formation without this ‘‘KLVFFA’’ re-
gion, the 22-35 sequence was chosen . The Italian (E22K) and Arctic (E22G)
point mutations lead to changes in time of fibril formation as well as solubility
and toxicity of fibrils. The single-point mutations are believed to promote early
onset of AD compared to the wild type (WT), prematurely producing clinical
and neuropathological features which are unchanged from those of late onset
AD. The use of Attenuated Total Reflection Infrared Spectroscopy, ATR-IR,
and Ultraviolet Visible Spectroscopy, UV-Vis, on the 22-35 sequence con-
firmed the formation of structures synonymous with toxic beta sheets. Using
Congo Red dye, which binds pentamerically to beta sheet fibrils, secondary
structures have been confirmed.
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Selected examples of turn sequence and hydrophobic contact stabilized b-hair-
pin peptides were previously studied using ECD, fluorescence, IR and VCD
spectroscopies to assess stability of b-hairpin formation. Extending this, two
three-stranded b-sheet peptides, based on modified Trpzip sequences, using
D-Pro-Gly (B3pG) or Asn-Gly (B3GN) turn sequences gave ECD spectra re-
flecting cross-strand Trp-Tyr aromatic interactions, and indicated both were
partially multi-stranded. Both showed initial IR spectra at low temperatures in-
dicative of extended b-sheet structure that were more characteristic of an aggre-
gate than a small oligomer structure. Thermal variation of their IR spectra gave
strikingly different behaviors. B3pG reversibly unfolded from aggregated b-
like structure at low temperature to disordered at high temperature. B3GN
formed aggregates at low temperature, became disordered with heating, but
upon re-cooling gave typical soluble b-sheet peptide spectra, which was could
be reversibly unfolded. ThT binding to dilute B3GN, but not B3pG, caused
a fluorescence enhancement, consistent with fibril formation. These results sug-
gest that turn sequence mutation leads to different micro- and macro-structures,
resulting in tuning their structurally related properties. Modifying the se-
quences to reduce hydrophobicity (aromatic residues) but incorporate
Aib-Gly turns gave partially folded peptides with reversible folding but less sta-
bility. Taking another view of b-sheet based peptide aggregation, we studied
fibril formation in glutamic acid oligomers at low pH (b2 form). We had shown
that poly-Glu IR is relatively insensitive to mixing of D and L isomers, which
causes a loss of long range order (fibrilization), as seen in EM, but VCD ishypersentive to this change, providing a new way of detection of long range
ordering (chirality) in fibril formation as opposed to aggregate forms. The
oligo-Glu peptide models add isotopic labeling to provide new insight into
the structure of the fibrils formed.
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Antibodies are composed of heavy chains and light chains. In Light Chain Am-
yloidosis (AL), antibody-secreting cells export only the light chains. These
light chains are prone to misfold, forming amyloid fibers, which get deposited
in various organs, leading to organ disfunction and patient death. The transition
from the native state to the amyloid fiber requires partial or total denaturation.
The structures of monomeric precursors to the oligomeric nuclei, or of those
assembled at the ends of the fibers, are unknown. There is an inverse correlation
between the stability of the native state and the speed of fiber formation, sug-
gesting that lower stability allows the population of ‘‘excited states’’ of the na-
tive ensemble, some of which could be amyloid fiber precursors. Starting from
the crystal structure of a variable light chain domain belonging to class 6a (one
of the most common in clinical cases of AL), we generated point mutants that
eliminate charges (R24G and D52A) or a proline (P7S). These mutants desta-
bilize the native state, and speed up fiber formation (for R24G and P7S). We
carried out MD simulations at three temperatures (298, 398 and 498K), to ex-
plore the effect of these mutations on the conformational landscape. We found
many metastable unfolding intermediates, which have eluded experimental de-
tection because their fluorescence is indistinguishable from that of the native
state. A common early unfolding intermediate exposes strand D, which has
a high potential for fiber formation according to ZipperDB. Those variants
with a higher speed of fiber formation expose this area with greater frequency.
We are thankful for computer resources at: Centro Nacional de Superco´mputo,
IPICyT; Kan Balam, UNAM; Sputnik, IBT-UNAM; Orion, FC and CIQ-
UAEM.
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Amyloid beta (Ab) proteins aggregate to form insoluble fibrils in the brains of
persons with Alzheimer’s disease (AD). X-ray diffraction studies reveal cross-
b structure in these fibrils, while solid state NMR studies indicate that this
structure consists of in-register parallel b-sheets. Proteins with these character-
istics accumulate in over a dozen different diseases, which have come to be
known as protein misfolding diseases. The trigger that induces the misfolding
of Ab proteins in AD is unknown, and neither is the mechanism by which
monomeric Ab proteins add to the growing end of a fibril. In order to
characterize the structure of Ab proteins under conditions in which they are
monomeric but not aggregated, we have encapsulated the 40-residue form
of the Ab protein (Ab40) into reverse micelles formed from sodium bis
(2-ethylhexyl) sulfosuccinate (AOT) and examined them with transmission
FTIR spectroscopy. Several types of evidence indicate that the encapsulated
proteins are monomeric, yet the spectra suggest that they have b-sheet second-
ary structure. The spectra of a polypeptide with the same amino acid composi-
tion as Ab40 but with a scrambled sequence show a random-coil structure.
These results suggest that Ab40 is capable of forming both antiparallel b struc-
tures in a reverse micelle, and parallel b structure in an amyloid fibril. We spec-
ulate that antiparallel b structure may help pre-organize the protein for adding
onto the end of a growing fibril.
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The accumulation of misfolded amyloid proteins has proven to be the common
link between neurodegenerative diseases such as Alzheimer’s, Huntington’s,
and Parkinson’s disease. According to previous studies done by numerous
